Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Exitfund is a venture capital organization based in Los Altos, California, focused on providing funding solutions for startups and early-stage companies. Founded to support entrepreneurs in their growth journey, Exitfund operates a platform that facilitates fundraising for startups while allowing angel investors to participate without carry. This unique model amplifies access to capital and fosters a community-driven approach to investment opportunities.
The organization primarily invests in early-stage companies, specifically targeting pre-seed through Series A startups. Exitfund aims to provide financial support and resources that enable startups to scale their operations and achieve their business objectives across various sectors, including AI, healthcare, biotech, defense, and SaaS.
Exitfund's commitment to supporting early-stage companies is evident in its investment strategy and operational model. The firm seeks to transform large markets by backing companies with innovative solutions and strong technical differentiation.
Exitfund invests primarily in early-stage companies, focusing on pre-seed, seed, and seed-plus stages. The organization targets sectors such as AI, healthcare, biotech, defense, and SaaS, aiming to provide financial support and resources that help startups scale effectively. The firm emphasizes investments in companies that have the potential to transform large markets, particularly those applying AI and deep technology to significant operational challenges.
In terms of investment structure, Exitfund operates a platform that allows angel investors to participate without carry, which broadens the capital network available to startups. This model not only facilitates fundraising efforts but also encourages a community-driven approach to investment opportunities. Founders looking to engage with Exitfund should be prepared to demonstrate how their startups can leverage technology to address large market needs.
Exitfund's portfolio includes several notable companies across various sectors:
Manish Kumar - Lead Associate / Lead Analyst at Exitfund. Manish is actively involved in sourcing and evaluating investment opportunities, particularly in AI, defense/security, and healthtech sectors. His insights are valuable for founders in these domains.
Kwesi Selassie - Team member at Exitfund, listed among the employees on LinkedIn. His specific investment role has not been independently verified.
Liam Mahoney - Another team member at Exitfund, also listed on LinkedIn. His investment role remains unverified.
Akancha Singh - Involved with content and company communications at Exitfund, as per her LinkedIn profile. Her role does not include confirmed investment decision-making.
Shilpa Raina - Head of Marketing at Exitfund, according to SignalHire. She has experience in marketing and communications within the venture capital space.
To pitch Exitfund, founders should visit their website at exitfund.com. It is recommended to include a clear overview of the business model, market opportunity, and how the startup plans to scale. While specific application forms or portals are not mentioned, a well-structured pitch deck is essential. Founders should expect a response time that varies based on the volume of submissions, and warm introductions may enhance the chances of engagement.
In recent activity, Exitfund has made several notable investments. In March 2025, they participated in a seed investment for Revision Dojo and a Series A investment for Infiuss Health. Additionally, they welcomed R2 Wireless into their portfolio, which specializes in AI-powered passive RF sensing for defense.
In October 2024, Exitfund was part of the Series A funding for Arda Therapeutics, which focuses on targeted cell depletion therapies for chronic diseases. Furthermore, they participated in a Series G round for Anthropic in February 2026, although this reflects platform participation rather than a traditional lead-investor role.
What are Exitfund's investment criteria?
Exitfund primarily invests in early-stage companies, focusing on pre-seed through Series A stages. The firm targets sectors such as AI, healthcare, biotech, defense, and SaaS. They look for startups that have the potential to transform large markets and demonstrate strong technical differentiation.
How can I pitch to Exitfund?
Founders interested in pitching to Exitfund can visit their website at exitfund.com. The platform provides a channel for startups to submit their pitches and applications. Specific details on what to include in the pitch deck are not disclosed, but clarity on the business model and market potential is essential.
What makes Exitfund different from traditional VCs?
Exitfund operates a unique platform that allows angel investors to participate without carry, which broadens the capital network available to startups. This community-driven approach enhances deal flow and provides startups with access to a wider range of resources and support.
What is the geographic focus of Exitfund?
Exitfund is based in the United States but has a global reach in terms of founder and investor connections. They are open to investing in startups that demonstrate significant market potential, regardless of their geographic location.
What kind of post-investment support does Exitfund provide?
While specific details on post-investment involvement are not disclosed, Exitfund emphasizes providing resources and access to a broad capital network to help startups scale their operations effectively.
What is the typical check size for investments?
Exitfund has not disclosed specific check sizes for their investments. However, they focus on early-stage funding, which typically involves smaller checks compared to later-stage investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.